Article thumbnail

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Yasunari Oki, Takashi Hirose, Toshimitsu Yamaoka, Sojiro Kusumoto, Takao Shirai, Tomohide Sugiyama, Kentaro Okuda, Masanao Nakashima, Yasunori Murata, Tohru Ohmori and Mitsuru Adachi
Publisher: Springer Science and Business Media LLC
Year: 2010
DOI identifier: 10.1007/s00280-010-1382-1
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.